Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.49 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.45 |
| ▸ | ALPL | P05186 | 1/20 | 0.45 |
| ▸ | XIAP | P98170 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KMO | O15229 | 1/20 | 0.43 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.43 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31435524 | 0.86 | TSHR (0.70) | TSHRRAB9AL3MBTL1BCHEENPP3 | |
| SCHEMBL6587897 | 0.80 | RAB9A (0.75) | TSHRRAB9AL3MBTL1CES2CES1 | |
| SCHEMBL22956030 | 0.78 | OXER1 (0.50) | TSHRRAB9AL3MBTL1OXER1BCHE | |
| SCHEMBL28389492 | 0.75 | OXER1 (0.47) | TSHRL3MBTL1OXER1KMT2AKMO | |
| SCHEMBL28661724 | 0.75 | OXER1 (0.63) | TSHRRAB9AL3MBTL1OXER1KMO | |
| SCHEMBL31435522 | 0.75 | RAB9A (0.66) | TSHRRAB9AL3MBTL1OXER1BCHE | |
| SCHEMBL23360817 | 0.73 | NOTUM (0.58) | OXER1HPGDKMO | |
| SCHEMBL22955291 | 0.72 | OXER1 (0.44) | TSHRRAB9AL3MBTL1OXER1NPC1 | |
| SCHEMBL22147535 | 0.72 | BCHE (0.80) | BCHEMEN1KMT2AHPGD | |
| SCHEMBL29936818 | 0.70 | TSHR (0.51) | TSHRRAB9AL3MBTL1OXER1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125348-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | OREGON STATE UNIVERSITY (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4710922-A2 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | Oregon State University (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4003337-B1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | UNIV OREGON STATE (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12473262-B2 | Aryl hydrocarbon receptor activators | OREGON STATE UNIVERSITY (US) | 2025-11-18 | — | — | US | disclosed |
| US-20220281824-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | OREGON STATE UNIVERSITY (US) | 2022-09-08 | — | — | US | disclosed |
| EP-4003337-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | Oregon State University (US) | 2022-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220281824-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | AHR, ARNT, NR0B1 | TSHR 40/4885RAB9A 3686/4885L3MBTL1 1457/4885 |
| US-20260125348-A1 | ARYL HYDROCARBON RECEPTOR ACTIVATORS | AHR, ARNT, NR1H2 | TSHR 13/4885RAB9A 2472/4885L3MBTL1 915/4885 |
| US-12473262-B2 | Aryl hydrocarbon receptor activators | AHR, ARNT, NR0B1 | TSHR 40/4885RAB9A 3686/4885L3MBTL1 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.